Portfolio company
ReproNovo
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
About
This biopharmaceutical company develops therapeutic treatments for male and female infertility and uterine conditions for patients worldwide.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Dioseve
This biotechnology company develops induced pluripotent stem cell-derived oocytes and ovarian somatic cells to treat infertility patients who cannot produce viable eggs.
ReproGo
This regenerative medicine company develops stem cell-derived vascular cells and organoids for drug screening and treating chronic wounds and cardiovascular diseases.
IntrepidiaBio
This biopharmaceutical company develops therapeutic products to address unmet medical needs for patients.
Ardana
This company develops and markets pharmaceutical products focused on reproductive health for patients and healthcare providers.
Gameto
This biotechnology company develops cell-based therapies and egg maturation protocols for fertility clinics and patients undergoing reproductive treatments.
Paterna Biosciences
Paterna Biosciences develops in vitro spermatogenesis technology to produce functional sperm from stem cells for clinics treating male infertility.
Vitra Bio
This biotechnology company develops in vitro fertilization technology and cell-based therapies to induce oogenesis outside the ovary for patients struggling with infertility.
Freya Biosciences
This company develops microbial immunotherapies targeting the vaginal microbiome to treat infertility and other reproductive health conditions for women.